inhaled prostacyclinoral phosphodiesterase inhibitororal endothelin receptor antagonistHepatopulmonary syndromePortopulmonary hypertensionportal hypertensionperoxisomal biogenesis disorderPoPHveno-occlusive disease
…hodiesterase inhibitor, oral endothelin receptor antagonist and inhaled prostacyclin). Currently, she is being consider for portosystemic shunt clos…